VN-0200

BIOLOGICAL2 trials

Sponsors

Daiichi Sankyo Co., Ltd., Daiichi Sankyo

Conditions

Respiratory Syncytial Virus Infections

Phase 1

Study of VN-0200 in Japanese Healthy Adults and Elderly Subjects

CompletedNCT04914520

Daiichi Sankyo Co., Ltd.Respiratory Syncytial Virus Infections

Start: 2021-06-11End: 2021-12-16Updated: 2021-12-22

Phase 2

A Dose Finding Study of VN-0200

CompletedNCT05547087

Daiichi SankyoRespiratory Syncytial Virus Infections

Start: 2022-10-13End: 2024-02-15Updated: 2024-02-29